Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture

Stroke

Volumn 42, Issue 11, 2011, Pages 3003-3004

  Tymianski, Michael ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NEUROPROTECTIVE AGENT;

ARTHRITIS; BRAIN ARTERY ANEURYSM RUPTURE; COHORT ANALYSIS; EDITORIAL; FOLLOW UP; HEART INFARCTION; HUMAN; INTRACRANIAL ANEURYSM; NEUROPROTECTION; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION; TRANSIENT ISCHEMIC ATTACK;

ANEURYSM, RUPTURED; ASPIRIN; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE;

EID: 80054991118     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.626762     Document Type: Editorial

References (3)

1. Krings T, Mandell D, Rasmus K, Geibprasert S, Tymianski M, Alvarez H, terBrugge KG, Hans F. Intracranial aneurysms: from vessel wall pathology to therapeutic approach. Nat Rev Neurol.. Epub ahead of print September 20, 2011. DOI: 10.1038/nrneurol.2011.136.
2. Hasan DM, Mahaney KB, Brown RD, Meissner I, Piepgras DG, Huston J, Capuano AW, Torner JC. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42: 3156-3162.
3. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103-110. (Pubitemid 36831019)